Delivery Order SPE2DX22D0010-SPE2D825FFM60

Award Date 5/7/25
Potential Completion Date 5/8/25
Potential Value $2.7K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $1,259.42, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the medication AZSTARYS 39.2 MG-7.8 MG CAP 100S, with a completion date of April 21, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $1,096.07, is a firm fixed-price delivery order for AZSTARYS CAPS 52.3MG/10.4MG. The contract has an ultimate completion date of January 17, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, issued by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has a ceiling value of $2,531.52 and an ultimate completion date of March 17, 2025. It is a delivery order contract for the supply of pharmaceutical products, including AZSTARYS capsules, with a firm fixed price pricing type. The contract is not designated as a set-aside....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,248.93, is for the supply of the drug AZSTARYS 26.1 MG-5.2 MG CAP 100S. The award has a period of performance through February 19, 2025 and is a firm fixed-price contract. The contract is not set aside for any specific business category. AmerisourceBergen holds a significant Indefinite...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,983.06, is for the supply of AZSTARYS 26.1 MG-5.2 MG CAP 100S, a pharmaceutical product. The contract is a firm fixed-price delivery order with a completion date of May 2, 2025. Amerisourcebergen Drug Corp is the prime contractor, and there is no set-aside designation...
This is a delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of pharmaceutical and medical products, including medications such as Azstarys capsules. The contract has a ceiling value of $4,769.82 and a period of performance through May 6, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen with DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of AZSTARYS 39.2 MG-7.8 MG CAP 100S, a prescription medication. The contract has a ceiling value of $1,156.16 and is a Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA), a defense agency. The contract has no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of AZSTARYS 39.2 MG-7.8 MG CAP 100S, a pharmaceutical product, with a ceiling value of $1,436.84 and a period of performance through April 24, 2025. The contract is not designated as a set-aside and was competitively awarded. AmerisourceBergen Drug Corp holds a larger...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,169.97 contract is for the supply of AZSTARYS capsules, a medication used for the treatment of attention-deficit/hyperactivity disorder (ADHD). The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract...
This federal contract award, valued at $2,782.03, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is a delivery order contract with a firm fixed price, with an ultimate completion date of April 21, 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
  • SPE2DX22D0010
    Indefinite Delivery Contract
  • SPE2DX22D0010-SPE2D825FFM60
    Delivery Order

This federal contract award, valued at $2,685.60, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order (SPE2DX22D0010|SPE2D825FFM60) for the pharmaceutical product AZSTARYS CAPS 52.3MG/10.4MG, with a performance period ending on May 8, 2025.

Amerisourcebergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This current delivery order is likely part of that broader IDC, enabling Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including the Defense Health Agency and U.S. Coast Guard. The contract is not designated as a set-aside.

Generated 8/6/25, 9:52 AM